Champion Technologies Inc.

Fresno, CA, United States

Champion Technologies Inc.

Fresno, CA, United States
SEARCH FILTERS
Time filter
Source Type

Warranty Tracker™ helps providers automate and streamline the warranty reimbursement process for implanted medical devices including pacemakers and defibrillators, cochlear implants, and neuro stimulators. The Centers for Medicare and Medicaid Services (CMS), requires hospitals to obtain available credits from manufacturers for replaced medical devices and to keep records of the credits they receive.  Currently a provider must undergo a complex series of manual steps without clear visibility into the reimbursement status of returned devices in order to receive full or partial credit from manufacturers for devices that are covered under warranty. Providers are subject to audit by the Office of Inspector General (OIG) and want to ensure the reimbursements from manufacturers are up to date and accurate. In October 2016, The Wall Street Journal reported the U.S. government "spent $1.5 billion in taxpayer dollars to treat 375,000 Medicare patients who received faulty cardiac implants.1"  OIG audits confirm overpayments to providers due to issues including improper tracking of device warranty credits from manufacturers.  These credits can amount to thousands of dollars per patient and CMS can levy fines to hospitals it judges noncompliant in securing warranty credits which are due without applying those credits to the patient's bill. "We're very proud to work with Mayo Clinic to provide hospitals with a management tool that solves the complex problem of capturing warranty reimbursement dollars and document refunds to Medicare for overpayments on replacement devices," said Peter Casady, Chief Executive Officer of Champion Healthcare Technologies. "The Warranty Tracker solution draws on Champion's core expertise developing medical device management systems that improve patient safety and compliance and reduce hospital operating costs." Under the agreement, Champion and Mayo co-developed the warranty credit management software and conducted beta testing at Mayo Clinic. "The process for tracking device warranties can be challenging due to many touchpoints and we at Mayo Clinic have been proactive to improve the processes and efficiency," says Paul Friedman, M.D., a cardiologist at Mayo Clinic who has collaborated on the project. Champion holds the exclusive global marketing license.  The warranty credit management solution, Warranty Tracker™, can be incorporated as a module in Champion's UDITracker® Interventional or UDITracker® OR software solutions. Mayo Clinic and Dr. Paul Friedman have a financial interest in the technology referenced in this news release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research. About Champion Healthcare Technologies Champion Healthcare Technologies is a privately held, healthcare information technology company and leader in tissue tracking and implantable medical device management systems (MDMS) for hospitals. Champion's flagship system UDITracker® captures, documents and shares medical implant information between patient care and supply chain information systems, empowering hospitals with the insights they need to increase patient safety and drive down operating costs.


Patent
Champion Technologies Inc. | Date: 2013-12-17

Functionalized alpha-hydroxy alkyl ethers have been found to perform as non (or anti-) scaling hydrogen sulfide scavengers. A method of scavenging hydrogen sulfide includes contacting a fluid containing hydrogen sulfide with a treatment fluid including a functionalized alpha-hydroxy alkyl ether. Accordingly, the alpha-hydroxy alkyl ether reacts with the hydrogen sulfide to reduce the amount of hydrogen sulfide in the fluid. The functionalized alpha-hydroxy alkyl ether is functionalized with a phosphate group, phosphonate group, sulfate group, or sulfonate group. A broad range of alpha-hydroxy alkyl ethers are disclosed.


Patent
Champion Technologies Inc. | Date: 2013-12-17

A method of performing a squeeze treatment comprises pumping a treatment fluid under pressure through a wellbore into a subterranean formation, wherein the treatment fluid includes a hydrogen sulfide scavenging compound that adsorbs onto the subterranean formation in a region around the wellbore. Production fluids are then allowed to flow from the subterranean formation into the wellbore, wherein the production fluids contact the adsorbed hydrogen sulfide scavenging compound as the production fluids flow through the region around the wellbore, and wherein the production fluids contain hydrogen sulfide that reacts with the hydrogen sulfide scavenging compound to reduce an amount of hydrogen sulfide in the production fluids before the production fluids flow into the wellbore.


Patent
Champion Technologies Inc. | Date: 2013-12-17

Alpha-hydroxy alkyl esters have been found to perform as hydrogen sulfide scavengers. A method of scavenging hydrogen sulfide includes contacting a fluid containing hydrogen sulfide with a treatment fluid including an alpha-hydroxy alkyl ester. Accordingly, the alpha-hydroxy alkyl ester reacts with the hydrogen sulfide to reduce the amount of hydrogen sulfide in the fluid. A broad range of alpha-hydroxy alkyl esters are disclosed.


Patent
Champion Technologies Inc. | Date: 2012-02-17

A thermal phase separation simulator and method for testing chemicals is disclosed. The simulator comprises a circular block heater carousel mounted for rotation on a stage. The carousel includes a circular array of test wells for receiving a plurality of test bottles, a plurality of heating elements and thermocouples disposed between the wells. Each well has an illumination port and a vertical slit to the outside to allow visual observation or imaging of a vertical swatch of the bottle. An illumination source aligns with the illumination port of each well in response to rotation of the carousel. The method includes adding a mixed phase fluid to a plurality of bottles, adding a chemical agent to each bottle, and simulating a thermal phase separation. Images of the fluid in each bottle are captured and analyzed to determine the performance of the one or more chemical agents.


Patent
Champion Technologies Inc. | Date: 2013-05-15

An emulsion breaker composition, a method of making the emulsion breaker, and method of breaking an emulsion are disclosed. In one method, an emulsion is contacted with an effective amount of an emulsion breaker composition. The emulsion breaker is a linear or branched polymer having at least one branch, wherein each branch has a first polymer block having a backbone including a plurality of ester groups and a second polymer block including an alkoxylate, and wherein at least two of the ester groups are connected by a CR1R2 group. The emulsion breakers are preferably formed by reacting a polyol with a cyclic ester monomer in the presence of a first catalyst to form an intermediate polymer having a plurality of branches, wherein each branch has a backbone including a plurality of ester groups, and then reacting the intermediate polymer with at least one alkylene oxide species in the presence of a second catalyst to form an alkoxylate block on each branch.


Air and ammonia gas are introduced into a subterranean formation during the in-situ combustion to increase the mobility of hydrocarbons in a subterranean formation and facilitate recovery of the hydrocarbons from the subterranean formation. The air supports in-situ combustion of a portion of the hydrocarbon within the subterranean formation to form water and establish a combustion front. The ammonia gas contacts the hydrocarbons ahead of the combustion front and reacts in-situ with naphthenic acid in the hydrocarbon to form a surfactant. The hydrocarbons, water and surfactant then form an oil-in-water emulsion that drains more freely through the formation. A production well, in fluid communication with the hydrocarbons ahead of the combustion front, may be used to remove the oil-in-water emulsion from the subterranean formation.


Patent
Champion Technologies Inc. | Date: 2013-03-20

A subsea antifouling sign (40) and a method for mounting such a sign (40)on a structure (52) to be located subsea. The sign (40) comprises a body of an antifouling material, and a first surface of the body has indicia or markings thereon. An adhesive layer (44) or coating is provided on a second opposing surface, and a protective lining (46) is located on the adhesive layer or coating. The method comprises removing the protective lining (46) from the adhesive layer (44) or coating; and attaching the subsea antifouling sign (40) to the structure (52) by adhering the adhesive layer (44) or coating to a surface of the structure (52).


Patent
Champion Technologies Inc. | Date: 2012-04-19

Polymeric naphthenate inhibitors are delivered into production fluids to contact mixtures of oil and water, such as in a hydrocarbon producing formation, production equipment, or processing systems. These polymeric naphthenate inhibitors exhibit surface-active properties causing the inhibitors to self-associate at oil-water interfaces and inhibit interactions between organic acids in the oil and cations or cation complexes in water. The large surface area makes these polymers persistent and effective at low concentrations. These compounds also inhibit aggregation of organic acid carboxylate salts that form when pH and pressure conditions are amenable to organic acid ionization. Preferred inhibitors do not form emulsions due to the formation of unstable mixed interface structures that result in coalescence of dispersed droplets. Naphthenate inhibitor dosages less than 100 ppm can effectively inhibit naphthenate salts or other organic acid salts that can form precipitates or emulsions during crude oil production or processing.


Patent
Champion Technologies Inc. | Date: 2016-06-23

A method for increasing the retention of a scale inhibitor within a hydrocarbon producing system is provided. The method includes, the steps of: (i) pre-flushing the system with a liquid; (ii) treating the system with a scale inhibitor; and (iii) over-flushing the system with a composition comprising an ionic polymer and a liquid carrier. The concentration of the ionic polymer in the composition is 5 to 50% wt.

Loading Champion Technologies Inc. collaborators
Loading Champion Technologies Inc. collaborators